As more regular procedures return, the Innovia Medical family of companies
is increasing its manufacturing capacity to ensure our customers have the products they require.
DTR Medical’s Single-use instrument eliminates cross contamination, inadequate samples and repeat procedures making it the instrument on choice for busy Colposcopy clinics dealing with the COVID-19 patient backlog. With around 2.1 million people currently waiting for breast, bowel or cervical screening in the UK and Cervical cancer screening down 68% in the USA, the importance of a good biopsy is essential in reducing time to an accurate diagnosis. This has had a global impact with 42% of countries’ cancer treatment having been severely disrupted since the beginning of the COVID-19 pandemic.
What’s more, DTR Medical’s Biopsy Punch
ensures a high-quality sample to be taken, even from a hardened cervix, leading to efficient pathology laboratory results and quick diagnosis. This removes the dilemmas clinics face when experiencing blunted reusable instruments that is; inadequate sampling, the impact in having to find an alternative handle or having to rearrange appointments to a different day resulting in patient recall.
For regular updates from across the Group, make sure you follow this blog weekly and our social media